Skip to main content
. 2023 Jan 18;29(2):348–357. doi: 10.1038/s41591-023-02219-5

Extended Data Fig. 2. Use of ELISA assay to discriminate infection from vaccine immunity by vaccination cohort.

Extended Data Fig. 2

This figure summarizes the in-house ELISA assays (green) we used to test for seropositivity amongst study subjects in different vaccination cohorts (orange). We did not test for seropositivity amongst heterologously vaccinated study subjects, study subjects who received vaccines other than BNT162b2 or CoronaVac, or study subjects with an un-determined vaccination history.